Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 17, 2022 - Issue
Submit an article Journal homepage
173
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year

Kuo-Chen Cheng1 Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
,
Chih-Cheng Lai2 Department of Internal Medicine, Kaohsiung Veterans General Hospital Tainan Branch, Tainan, TaiwanORCID Iconhttps://orcid.org/0000-0002-6334-2388
ORCID Icon,
Cheng-Yi Wang3 Department of Internal Medicine, Cardinal Tien Hospital, New Taipei City, TaiwanORCID Iconhttps://orcid.org/0000-0001-7426-0743
ORCID Icon,
Ching-Min Wang4 Department of Internal Medicine, Chi Mei Medical Center, Liouying, Taiwan
,
Chung-Han Ho5 Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan;6 Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, 11695, Taiwan;7 Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, TaiwanORCID Iconhttps://orcid.org/0000-0001-5925-8477
ORCID Icon,
Mei-I Sung1 Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
,
Shu-Chen Hsing1 Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
,
Kuang-Ming Liao8 Department of Internal Medicine, Chi Mei Medical Center, Chiali, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4364-8248
ORCID Icon &
Shian-Chin Ko1 Department of Internal Medicine, Chi Mei Medical Center, Tainan, TaiwanCorrespondence[email protected]
 show all
Pages 883-891 | Published online: 21 Apr 2022

References

  • Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234. doi:10.1136/bmj.m234
  • GBD 2015 Chronic Respiratory Disease Collaborators.. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
  • Wang YC, Lin JM, Li CY, Lee LT, Guo YL, Sung FC. Prevalence and risks of chronic airway obstruction: a population cohort study in Taiwan. Chest. 2007;131(3):705–710. doi:10.1378/chest.06-1829
  • Lim S, Lam DC, Muttalif AR, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14(1):4.
  • Lin CH, Yu CJ, Wang HC, Lin MC, Cheng SL. The beneficial effect of COPD pay-for-performance program in Taiwan. In: International perspectives on pulmonary and critical care medicine. American Thoracic Society; 2020:A6566.
  • Puebla Neira DA, Hsu ES, Kuo YF, Ottenbacher KJ, Sharma G. Readmissions reduction program: mortality and readmissions for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(4):437–446. doi:10.1164/rccm.202002-0310OC
  • Myers LC, Faridi MK, Hasegawa K, Hanania NA, Camargo CA Jr. The hospital readmissions reduction program and readmissions for chronic obstructive pulmonary disease, 2006–2015. Ann Am Thorac Soc. 2020;17(4):450–456. doi:10.1513/AnnalsATS.201909-672OC
  • Anastasaki M, Trigoni M, Pantouvaki A, et al. Establishing a pulmonary rehabilitation programme in primary care in Greece: a FRESH AIR implementation study. Chron Respir Dis. 2019;16:1479973119882939. doi:10.1177/1479973119882939
  • Park HJ, Kim SR, Kim S, et al. Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease. Respir Res. 2021;22(1):87. doi:10.1186/s12931-021-01684-1
  • Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24-36.
  • Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69.
  • Decramer M, Bartsch P, Pauwels R, Yernault JC. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis. 2003;59(1):62–80.
  • Fritsch K, Jacot ML, Klarer A, et al. Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital. Swiss Med Wkly. 2005;135(7–8):116–121.
  • Asche CV, Leader S, Plauschinat C, et al. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2012;7:201–209. doi:10.2147/COPD.S25805
  • Sehl J, O’Doherty J, O’Connor R, O’Sullivan B, O’Regan A. Adherence to COPD management guidelines in general practice? A review of the literature. Ir J Med Sci. 2018;187(2):403–407. doi:10.1007/s11845-017-1651-7
  • Świątoniowska N, Chabowski M, Polański J, Mazur G, Jankowska-Polańska B. Adherence to therapy in chronic obstructive pulmonary disease: a systematic review. Adv Exp Med Biol. 2020;1271:37–47.
  • Cousins JL, Wood-Baker R, Wark PAB, et al. Management of acute COPD exacerbations in Australia: do we follow the guidelines? ERJ Open Res. 2020;6(2):00270–2019. doi:10.1183/23120541.00270-2019
  • Torres-Robles A, Benrimoj SI, Gastelurrutia MA, et al. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf. 2022;31(2):105–115. doi:10.1136/bmjqs-2020-011671
  • Chan KP, Ko FW, Chan HS, et al. Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017;12:3371–3379. doi:10.2147/COPD.S147070
  • Papaioannou AI, Loukides S, Bakakos P, et al. Dual bronchodilator in the era of triple therapy. Int J Chron Obstruct Pulmon Dis. 2020;15:2695–2705. doi:10.2147/COPD.S273987

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.